Central Sleep Apnea and Its Phenotypes: Why does it Matter?
Central Sleep Apnea and Its Phenotypes: The Importance of Screening and Treatment Obstructive sleep apnea (OSA) is the most common […]
Central Sleep Apnea and Its Phenotypes: The Importance of Screening and Treatment Obstructive sleep apnea (OSA) is the most common […]
A Legacy of Innovation Founded in 1982, SEFAM has been a leader in sleep medicine innovation. Their development of Europe’s
Sleep apnoea is a common condition that is unrecognised and is thought to affect millions of people globally. Multiple breathing
Upper Airway Resistance Syndrome (UARS) is a sleep disorder characterised by partial obstruction of the upper airways during sleep. Unlike
Understanding the link between sleep-related breathing disorders is crucial in providing personalised care to patients. One often overlooked relationship is
Sefam UK understands the requirements of individuals relying on CPAP therapy to treat Sleep Apnoea and offers a range of
The Sunrise device is an innovative screening and diagnostic device designed to aid in the efficient diagnosis of sleep apnoea
Sleep apnoea syndrome is a prevalent condition that has led to advancements in personalised sleep apnoea therapy, affecting millions globally.
Sleep apnoea is a common sleep disorder that is estimated to affect 963 million adults between the ages 30-69 years
Sleep apnea is a common and much underdiagnosed sleep-related breathing disorder that has been reported to affect millions of people
Personalised Sleep Apnoea Treatment for people with sleep apnea is an important consideration for sleep medicine clinicians. A clear understanding
The development of Continuous Positive Airway Pressure (CPAP) therapy devices almost 30 years ago by the Australian Physician Dr Colin